NYSE:BSXMedical Equipment
Boston Scientific (BSX) Margin Expansion Reinforces Bullish Profitability Narratives
Boston Scientific (BSX) has wrapped up FY 2025 with fourth quarter revenue of US$5.3b, basic EPS of US$0.45 and net income excluding extra items of US$672m. On a trailing twelve month basis, revenue reached US$20.1b, EPS was US$1.96 and net income excluding extra items came in at US$2.9b. Over the past six reported quarters, the company has seen quarterly revenue move from US$4.2b in Q3 2024 to between US$4.7b and US$5.3b in FY 2025. Basic EPS has ranged from US$0.32 in Q3 2024 to US$0.54 in...